GAM
JAZZ icon

Groupama Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Groupama Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$487K Hold
2,576
– – 0.01% 302
2025
Q4 		$438K Hold
2,576
– – 0.01% 355
2025
Q3 		$340K Sell
2,576
-6,142
-70% -$737K 0.01% 404
2025
Q2 		$932K Hold
8,718
– – 0.02% 285
2025
Q1 		$1.07M Buy
8,718
+619
+8% +$80.8K 0.02% 243
2024
Q4 		$996K Buy
8,099
+1,305
+19% +$154K 0.02% 274
2024
Q3 		$608K Buy
6,794
+309
+5% +$33.9K 0.02% 326
2024
Q2 		$692K Sell
6,485
-1,217
-16% -$134K 0.01% 339
2024
Q1 		$933K Sell
7,702
-58,858
-88% -$7.21M 0.02% 320
2023
Q4 		$8.19M Buy
+66,560
New +$8.31M 0.21% 90

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Groupama Asset Management's JAZZ Position: Q1 2026 in Review

Groupama Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 2,576 shares worth $487K. The position accounts for 0.01% of the portfolio, ranked #302.

Groupama Asset Management first reported a position in JAZZ in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.19M in Q4 2023. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Groupama Asset Management held 2,576 shares of Jazz Pharmaceuticals worth $487K as of Q1 2026.
  • Groupama Asset Management left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up 0.01% of Groupama Asset Management's portfolio in Q1 2026, its #302 holding.
  • Groupama Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • Groupama Asset Management's Jazz Pharmaceuticals position peaked at $8.19M in Q4 2023.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Groupama Asset Management's 13F filing for Q1 2026, filed 22 May 2026.